Hearing:
Lowering Costs for Patients: The Health of the Biosimilar Market
Subcommittee on Health (Committee on Ways and Means)
Tuesday, April 8, 2025 (10:00 AM)
1100 LHOB
Washington, D.C.
Witnesses
Craig Burton
Executive Director, Biosimilars Council
Added
04/06/2025 at 10:02 AM
- Burton Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Burton Truth in Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Burton Bio
[PDF]
Added
04/08/2025 at 10:14 AM
Dr. Colin Edgerton
Director, Articularis Healthcare Group
Added
04/06/2025 at 10:02 AM
- Edgerton Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Edgerton Truth in Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Edgerton Bio
[PDF]
Added
04/08/2025 at 10:14 AM
Dr. Aaron Kesselheim
Professor of Medicine, Harvard University
Added
04/06/2025 at 10:02 AM
- Kesselheim Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Kesselheim Truth in Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Kesselheim Bio
[PDF]
Added
04/08/2025 at 10:14 AM
Dr. Debra Patt
President, Community Oncology Alliance
Added
04/06/2025 at 10:02 AM
- Patt Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Patt Truth in Testimony
[PDF]
Added
04/08/2025 at 10:14 AM
- Patt Bio
[PDF]
Added
04/08/2025 at 10:14 AM
First Published:
April 1, 2025 at 04:24 PM
Last Updated:
April 8, 2025 at 10:14 AM